Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman
Seif Al Abri, Akiko Kowada, Fatma Yaqoubi and 3 more
International Journal of Infectious Diseases · 2020
doi:10.1016/j.ijid.2020.03.010 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Objective: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman. Methods: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment. Results: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved. Conclusions: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention. Keywords: Latent tuberculosis, Screening, Cost, DAILYs
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.